Pérez-Molina JA - Search Results

1

Pérez-Molina JA, Molina I. Pérez-Molina JA, et al. Lancet. 2018 Jan 6;391(10115):82-94. doi: 10.1016/S0140-6736(17)31612-4. Epub 2017 Jun 30. Lancet. 2018. PMID: 28673423 Review.

2

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis.

Pérez-Molina JA, Pérez-Ayala A, Moreno S, Fernández-González MC, Zamora J, López-Velez R. Pérez-Molina JA, et al. J Antimicrob Chemother. 2009 Dec;64(6):1139-47. doi: 10.1093/jac/dkp357. Epub 2009 Oct 9. J Antimicrob Chemother. 2009. PMID: 19819909 Review.

3

Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.

Pérez-Molina JA, Norman F, López-Vélez R. Pérez-Molina JA, et al. Curr Infect Dis Rep. 2012 Jun;14(3):263-74. doi: 10.1007/s11908-012-0259-3. Curr Infect Dis Rep. 2012. PMID: 22477037

4

Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.

Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R. Pérez-Molina JA, et al. Acta Trop. 2013 Aug;127(2):101-4. doi: 10.1016/j.actatropica.2013.04.003. Epub 2013 Apr 11. Acta Trop. 2013. PMID: 23583863

5

The Trypanosoma cruzi satellite DNA OligoC-TesT and Trypanosoma cruzi kinetoplast DNA OligoC-TesT for diagnosis of Chagas disease: a multi-cohort comparative evaluation study.

De Winne K, Büscher P, Luquetti AO, Tavares SB, Oliveira RA, Solari A, Zulantay I, Apt W, Diosque P, Monje Rumi M, Gironès N, Fresno M, Lopez-Velez R, Perez-Molina JA, Monge-Maillo B, Garcia L, Deborggraeve S. De Winne K, et al. PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2633. doi: 10.1371/journal.pntd.0002633. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 24392177 Free PMC article.

6

Old and new challenges in Chagas disease.

Pérez-Molina JA, Perez AM, Norman FF, Monge-Maillo B, López-Vélez R. Pérez-Molina JA, et al. Lancet Infect Dis. 2015 Nov;15(11):1347-56. doi: 10.1016/S1473-3099(15)00243-1. Epub 2015 Jul 28. Lancet Infect Dis. 2015. PMID: 26231478

7

Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.

Vallejo A, Monge-Maillo B, Gutiérrez C, Norman FF, López-Vélez R, Pérez-Molina JA. Vallejo A, et al. Acta Trop. 2016 Dec;164:117-124. doi: 10.1016/j.actatropica.2016.09.010. Epub 2016 Sep 9. Acta Trop. 2016. PMID: 27619190 Clinical Trial.

8

6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain.

Pérez-Molina JA, López-Polín A, Treviño B, Molina I, Goikoetxea J, Díaz-Menéndez M, Torrús D, Calabuig E, Benito A, López-Vélez R; +Redivi Study Group. Pérez-Molina JA, et al. J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax035. J Travel Med. 2017. PMID: 28931128

9

Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease.

Crespillo-Andújar C, Calbacho Robles M, Norman FF, Pérez-Molina JA. Crespillo-Andújar C, et al. BMJ Case Rep. 2018 Mar 27;2018:bcr2017223788. doi: 10.1136/bcr-2017-223788. BMJ Case Rep. 2018. PMID: 29588298 Free PMC article.

10

Chagas disease cardiomyopathy treatment remains a challenge - Authors' reply.

Pérez-Molina JA, Molina I. Pérez-Molina JA, et al. Lancet. 2018 Jun 2;391(10136):2209-2210. doi: 10.1016/S0140-6736(18)30776-1. Epub 2018 Jun 1. Lancet. 2018. PMID: 29893217 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page